Stock listing
EVGN Stock Price, News, Filings & Events — Evogene Ltd.
Selected listing: EVGN · NASDAQ · USD · US
This page tracks Evogene Ltd.'s EVGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EVGN:NASDAQ. EVGN:NASDAQ is the stock-level entry point for investors researching Evogene Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Evogene Ltd. is a public company traded under the ticker EVGN in the American market. The company has a market capitalization of approximately $6.57 million. Evogene focuses on developing innovative technologies to enhance agricultural productivity and sustainability.
- Ticker
- EVGN:NASDAQ
- Asset type
- Stock
- Market cap
- $8.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Evogene Ltd. EVGN:NASDAQ stock context
This page tracks Evogene Ltd.'s EVGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EVGN:NASDAQ. EVGN:NASDAQ is the stock-level entry point for investors researching Evogene Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Evogene Ltd. is a public company traded under the ticker EVGN in the American market. The company has a market capitalization of approximately $6.57 million. Evogene focuses on developing innovative technologies to enhance agricultural productivity and sustainability.
Latest news from Evogene Ltd.
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly...
August 25, 2026
Evogene Reports Second Quarter and First Half 2026 Financial Results
August 18, 2026
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
August 14, 2026
Evogene Schedules Second Quarter 2026 Financial Results Release
July 30, 2026
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipide...
July 22, 2026
Research Evogene Ltd.
Evogene Ltd. investor report
Review AI stock analysis and investor report context for EVGN:NASDAQ.
Evogene Ltd. company profile
View the public company page for Evogene Ltd. on 6ix.
Evogene Ltd. news
Read company news and market updates connected to Evogene Ltd..
Evogene Ltd. investor events
Find investor webinars, events, and replay context for Evogene Ltd..